A new small-molecule drug produced a rapid antidepressant response similar to that of ketamine when tested in mice, a new Yale-led study published April 16 in The Journal of Clinical Investigation shows.
The effects of the drug, called NV-5138, in rodent models mimicked the rapid actions of the anesthetic ketamine, a variation of which, Esketamine, was recently approved by the FDA for use in depressed patients who do not respond to other medications. However, there still remain lingering safety concerns over use of ketamine, as well as Esketamine, both of which have the potential to induce psychosis-like states and also have a potential for abuse.
“Recent research has raised the possibility that a new drug, such as NV-5138, could be developed that is rapid-acting but also more efficacious and safer than current formulations of ketamine,” said senior author Ron Duman, the Elizabeth Mears and House Jameson Professor of Psychiatry and professor of neuroscience.
The experimental drug does not directly stimulate neuronal activity like ketamine, but like ketamine, it spurs the growth of synapses or connections between neurons, the loss of which is associated with chronic stress and depression. The research team also showed that synaptic connectivity markers were rapidly restored in a mouse model of anhedonia, a core symptom of depression marked by an inability to experience pleasure. Mice administered a single dose of the drug also showed marked improvements in other depression-related behaviors.
The drug is being developed by Navitor Pharmaceuticals Inc., which funded the study. It is currently undergoing Phase I testing in human patients.
The Latest on: Depression
via Google News
The Latest on: Depression
- Antipsychotic Scores Win as Add-On Depression Therapy on May 22, 2019 at 1:17 pm
SAN FRANCISCO -- When added to standard treatment for patients with major depressive disorder (MDD), the atypical antipsychotic pimavanserin (Nuplazid) significantly improved symptoms of depression, ... […]
- What’s the Difference Between Bipolar Disorder and Depression? on May 22, 2019 at 6:39 am
You're sunk in a pit of hopelessness where it's a struggle to get out of bed in the morning, open the curtains or take a shower: It's all too much effort and what difference does it make? You're ... […]
- What Lies Beneath: Hypnotherapy Is Helping Me Get to the Bottom of My Depression on May 22, 2019 at 6:08 am
I’m afraid I’m going to fart in front of my therapist. Specifically, I’m afraid I’m going to fall asleep during therapy, and fart in my sleep (and don’t act like you never fart in your sleep, because ... […]
- New therapeutic target for depression identified on May 22, 2019 at 5:07 am
Depression is one of the most widespread disorders, and it is estimated that 4 million people are affected in Spain. There are different pharmacological treatments for depression, mainly therapies ... […]
- Veterans with depression and/or PTSD more likely to seek cardiac rehab on May 22, 2019 at 2:01 am
Veterans who have post-traumatic stress disorder (PTSD) and/or depression were more likely to use cardiac rehabilitation services after an episode of ischemic heart disease than those who didn't ... […]
- 'Mediterranean diet may protect against depression symptoms' on May 22, 2019 at 12:09 am
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current ... […]
- Esketamine nasal spray effective against treatment resistant depression on May 21, 2019 at 11:53 am
May 21 (UPI) --New research suggests esketamine nasal spray, a new antidepressant, is safe and effective for patients who have failed to respond to other types of treatment. More than a third of ... […]
- Brain study may explain why depression is more common in women on May 21, 2019 at 11:29 am
Researchers have scanned the brains of 115 participants and found that inflammation can lead to a loss of pleasure — called anhedonia — in women but not in men. Depression, the "leading cause of ... […]
- Mediterranean Diet May Keep Late-Life Depression at Bay on May 21, 2019 at 9:23 am
SAN FRANCISCO — Adherence to a Mediterranean diet may guard against late-life depression, new research shows. Investigators from Hellenic Open University in Patras, Greece, found that for older ... […]
- Exercise Could Be Prescribed to Treat Anxiety and Depression on May 21, 2019 at 7:11 am
Scientists behind a study showing exercise can ease the symptoms of disorders like depression hope working out could one day be prescribed to mental health patients in hospitals. The team behind the ... […]
via Bing News